Clinical Trials Logo

Filter by:
NCT ID: NCT05287594 Enrolling by invitation - Clinical trials for High Intensity Interval Training

Feasibility of a Train-the-Trainer Delivered Exercise Intervention in Firefighters

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

Purpose: To collect and report feasibility data for conducting a future cluster randomized trial to evaluate the efficacy of a TRAINER delivered integrated exercise program in career firefighters, and to determine intervention fidelity and preliminary effects of a TRAINER delivered integrated exercise program in career firefighters. Participants: 52 career firefighters 18 - 60 years old (40 trainees, 6 trainers, 6 administrators). Procedures (methods): Enrolled fire stations will be randomly assigned (3:2 allocation ratio) to a TRAINER or wait-list control (CON) group, stratified by city, using computer-generated random numbers. All enrolled firefighters will undergo a series of assessments at baseline (week 0) and post-testing (week 7) following the TRAINER delivered 6-week intervention.

NCT ID: NCT05287035 Enrolling by invitation - Spinal Fusion Clinical Trials

Spinal Fusions Steroid Study

SFSS
Start date: July 1, 2023
Phase: Early Phase 1
Study type: Interventional

Current efforts to improve pain alleviation focus on non-opioid pharmaceuticals. Intravenous perioperative corticosteroid administration has been suggested as an alternative method for post-operative pain control. The evidence regarding perioperative intravenous corticosteroids to help alleviate post-operative pain is mixed. Some meta-analyses report decreased opioid consumption and decreased pain intensity after a variety of surgical procedures. However, a study of larger orthopedic procedures found no benefit. The catabolic and immunosuppressant effects of corticosteroids also pose issues with wound healing and infection, which can have severe consequences after spine surgery. There is limited data on the effect of perioperative intravenous steroid administration on pain alleviation in children having surgery to address spine deformity. A recent retrospective review demonstrated that perioperative corticosteroid administration was associated with a statistically significant decrease in opioid medication utilization among children and adolescents after spinal deformity surgery. While not increasing the risk of postoperative complications. The investigators hypothesize that the administration of perioperative intravenous dexamethasone will demonstrate a clinically meaningful and statistically significant decrease in postoperative pain intensity, need for opioid medications, time to ambulation, and length of stay in children recovering from surgery for spine deformity.

NCT ID: NCT05285878 Enrolling by invitation - Clinical trials for Kidney Failure, Chronic

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Start date: July 28, 2022
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blind, placebo-controlled trial in de novo kidney transplant patients to determine if the addition of fingolimod (brand name Gilenya®, candidate name- FTY720) on the background of standard immunosuppression will prevent expansion of the interstitial compartment of the transplanted kidney. Interstitial expansion is the precursor of interstitial fibrosis and graft loss. The study will test the hypothesis that abgrogating the fibrogenic effects of both the RhoA and mTOR pathways with fingolimod will reduce structural damage in transplanted kidneys and possible subsequent transplant failure.

NCT ID: NCT05284513 Enrolling by invitation - Clinical trials for Familial Hypercholesterolemia

Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH)

CARE-FH
Start date: September 9, 2022
Phase: N/A
Study type: Interventional

Diagnosis rates of familial hypercholesterolemia (FH) are low in the United States, despite multiple guidelines and recommendations for screening and treatment of high cholesterol, to prevent heart attacks in those affected. Using a stepped-wedge design, the investigators plan to utilize tools from implementation science to improve uptake, acceptability, and sustainability of FH diagnostic programs in primary care settings. If successful, this study will provide tools generalizable to other health care systems to improve FH diagnosis rates.

NCT ID: NCT05282706 Enrolling by invitation - Nausea Clinical Trials

Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting

Start date: May 16, 2022
Phase: Phase 1
Study type: Interventional

Use of inhaled essential oils to reduce the symptoms of pain or nausea, enabling a patient to have increase participation with PT or OT, thereby minimizing hospitalization-related risks and potentially reducing the length of stay in the hospital.

NCT ID: NCT05281874 Enrolling by invitation - Alcohol Drinking Clinical Trials

Personalized Integrated Alcohol and Sexual Assault Prevention Among College Students

+Change
Start date: October 3, 2022
Phase: N/A
Study type: Interventional

Heavy episodic drinking and sexual assault are problematic on college campuses. This study includes a randomized controlled trial of Positive Change (+Change), an integrated alcohol and sexual assault prevention program, compared to an attention-matched control condition across two universities in reducing alcohol use, sexual assault victimization, sexual assault perpetration, and increasing sexual assault bystander intervention. This study will also test the efficacy of +Change plus Booster session, an identical version of +Change delivered 6 months after the baseline, compared to +Change alone in long-term reductions in alcohol use, sexual assault victimization, sexual assault perpetration, and increases in sexual assault bystander intervention. This research is the next step of a NIAAA-funded planning grant (R34AA025691).

NCT ID: NCT05281666 Enrolling by invitation - Laceration of Hand Clinical Trials

Suture Repair of Lacerations in the ED: Comparison Between Two Suture Materials

Start date: August 23, 2022
Phase: N/A
Study type: Interventional

This study aims to determine whether the use of non-absorbable (i.e. nylon) versus absorbable (i.e. chromic gut) sutures in traumatic hand lacerations affects wound healing, patient perception, and development of complications.

NCT ID: NCT05279742 Enrolling by invitation - Clinical trials for Chronic Kidney Diseases

Enhancing the Natriuretic Peptide System in HFpEF

Start date: November 4, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to look at the differences in how individuals with heart failure with preserved ejection fraction in the presence of chronic kidney disease (HFpEF-CKD) and exercise induced dyspnea without objective findings of fluid retention (HFpEF-EI) bodies function using drugs Sacubatril/Valsartan (Entresto) and MANP.

NCT ID: NCT05279027 Enrolling by invitation - Melanoma (Skin) Clinical Trials

Zr89 + PET Companion Trial

Start date: March 8, 2022
Phase: Early Phase 1
Study type: Interventional

Study of Zirconium Zr 89 Crefmirlimab Berdoxa PET/CT as an imaging biomarker for assessing an early response to therapy in patients with advanced melanoma on immunotherapy and hydroxychloroquine. This study is a companion study to the "LIMIT Melanoma Trial." Patients with melanoma who are potentially eligible for the LIMIT Melanoma Trial and have at least one site of measurable disease based on RECIST 1.1 are potentially eligible. Associations with progression-free survival (PFS) and overall survival (OS) will be tested.

NCT ID: NCT05278013 Enrolling by invitation - Ascites Clinical Trials

Utility of 2- Octyl Cyanoacrylate (2-OCA)

Start date: January 13, 2022
Phase: N/A
Study type: Interventional

Paracentesis is a commonly performed procedure in the inpatient and outpatient settings for treatment of ascites. The most frequent complication of paracentesis is fluid leak. Risk for this complication can be reduced by following the Z-track technique; however, fluid leaks still occur causing significant morbidity. 2-Octyl cyanoacrylate (2-OCA, Dermabond manufactured by Ethicon Inc) skin adhesive has been used for years for skin closure for wounds from surgical incisions including punctures from minimally invasive surgery and simple trauma lacerations.